TABLE 5.
Representative conditions for different cell types.
| Cell Type | Rules | Parameters | Predicted class |
|---|---|---|---|
| Blood B cells | Condition 0 | ENSG0000019609(PAX5) ≤ 2.1383 | Non-vaccinated |
| Condition 1 | ENSG0000019609(PAX5) > 0.3466 | 2*Attenuated | |
| Condition 2 | ENSG0000019609(PAX5) > 0.8959 | mRNA/Attenuated | |
| Nasal B cells | Condition 3 | ENSG00000119917(IFIT3) > 0.3466 | Non-vaccinated |
| Condition 4 | ENSG00000119917(IFIT3) > 0.8959 | mRNA/Attenuated | |
| Blood T cells | Condition 5 | ENSG00000221983(UBA52) ≤ 2.4414 | Non-vaccinated |
| Condition 6 | ENSG00000221983(UBA52) >2.4414 | 2*Adenovirus | |
| Condition 7 | ENSG00000221983(UBA52) > 2.1910 | 2*Attenuated | |
| Condition 8 | ENSG00000221983(UBA52) > 2.7403 | mRNA/Attenuated | |
| Nasal T cells | Condition 9 | ENSG00000233927(RPS28) ≤ 4.0687 | Non-vaccinated |
| Condition 10 | ENSG00000233927(RPS28) > 4.0687 | 2*Adenovirus | |
| Condition 11 | ENSG00000233927(RPS28) > 4.0687 | 2*Attenuated | |
| Lung macrophages | Condition 12 | ENSG00000163563(MNDA) > 3.5972 | Non-vaccinated |
| Condition 13 | ENSG00000163563(MNDA) ≤ 3.2385 | 2*Adenovirus | |
| Condition 14 | ENSG00000163563(MNDA) ≤ 3.5972 | 2*mRNA | |
| Condition 15 | ENSG00000163563(MNDA) ≤ 2.8029 | mRNA/Attenuated | |
| Nasal macrophages | Condition 16 | ENSG00000160932(LY6E) > 2.5249 | Non-vaccinated |
| Condition 17 | ENSG00000160932(LY6E) ≤ 2.5249 | 2*Adenovirus | |
| Condition 18 | ENSG00000160932(LY6E) ≤ 2.5249 | 2*Attenuated | |
| Condition 19 | ENSG00000160932(LY6E) ≤ 2.5249 | 2*mRNA | |
| Condition 20 | ENSG00000160932(LY6E) ≤ 2.5249 | mRNA/Attenuated | |
| Lung alveolar epitheial cells | Condition 21 | ENSG00000187608(ISG15) > 0.8959 | Non-vaccinated |
| Condition 22 | ENSG00000187608(ISG15) ≤ 0.8959 | 2*Adenovirus | |
| Condition 23 | ENSG00000187608(ISG15) ≤ 0.8959 | 2*Attenuated | |
| Lung endothelial cells | Condition 24 | ENSG00000204264(PSMB8) > 0.3466 | Non-vaccinated |
| Condition 25 | ENSG00000204264(PSMB8) ≤ 1.9945 | 2*Attenuated |